64 A 90-day administration of dexamethasone (DEX) resulted in significant declines in both BMD and BMC, along with substantial increases in serum levels of glucose, insulin, triglycerides, total cholesterol, parathyroid hormone (PTH), osteoprotegerin (OPG), and bone resorption markers including deoxypyridinoline (DPD), N-terminal telopeptide of type I collagen (NTX-1), and TRAP-5b
Pharmacokinetic Method Development: Validate HPLC and bioassay techniques for biphasic disposition profiling and clearance rate determination PubMed
Introduction Cancer mortality represents one of the most significant social, medical, and scientific primary challenges
Key benefits With an increased demand for GLP-1s, plan sponsors need an innovative weight management solution to reduce costs and improve outcomes